Retrogen, Inc.

Retrogen’s Clinical Laboratory Services are run under guidelines regulated by the Clinical Laboratories Improvement Amendments (CLIA) and under accreditation by the College of American Pathologist. Next-Gen and Sanger based genomics workflows have been optimized to provide industry leading quality and reliability.

Retrogen has been a trusted provider of quality genomic services since 1992. Founded by scientists experienced in high throughput DNA sequencing, human genomics and genetic research, we continue to use the most advanced technologies to offer a suite of solutions that accelerate your gene function studies and genetic disease analyses.

Retrogen, Inc. is located in San Diego, CA, United States and is part of the Biotechnology Research Services Industry. Retrogen, Inc. has 11 total employees across all of its locations and generates $1.41 million in sales (USD).

Our mission is to become the partner of choice for researchers, physicians, and genetic counselors. We promise to quickly and securely deliver the highest quality results. We help scientists accomplish research projects faster, without additional expense. We help medical professionals accurately diagnose and the improve quality of life for people with clinical conditions.

Retrogen’s Clinical Laboratory Services are run under guidelines regulated by the Clinical Laboratories Improvement Amendments (CLIA) and under accreditation by the College of American Pathologist. Next-Gen and Sanger based genomics workflows have been optimized to provide industry leading quality and reliability.

1992